Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • arthur.yxt
    Member
    • Oct 2009
    • 10

    #1

    Bowie12Beta mapping direction restriction or bug?

    Dear all, I was trying to map 76nt reads using Bowtie. I wanted to use the "seed" feature to avoid trimming off the adapter sequence.

    1) this is the sequence that I trimmed off the last "4nt" long "adapter", which is not really the adapter, and I got it mapped.
    HWUSI-EAS1621.1.2.1.5.745.0 16 chr1 173833971 255 72M * 0 0 CATCAGATAGGAGCGAAAGACTTAATATTGCTCATCAGCGTTAGTCTGCTGAACTATGTTATCATCATTGTA ;:;143>>=9:>:+=A?B78A?BBAB@@@=B<AA@B@;?0>BA8>A@7@ABB<BBBABBAA?:?BACCBABB XA:i:0 MD:Z:72 NM:i:0

    2) so now I map the non-trimmed 76nt sequence, it turned out unmapped.
    HWUSI-EAS1621.1.2.1.5.745.0 4 * 0 0 * * 0 0 TACAATGATGATAACATAGTTCAGCAGACTAACGCTGATGAGCAATATTAAGTCTTTCGCTCCTATCTGATGATCT BBABCCAB?:?AABBABBB<BBA@7@A>8AB>0?;@B@AA<B=@@@BABB?A87B?A=+:>:9=>>341;:;<919 XM:i:0

    my parameters: -q -n 3 -l 30 -k 10 --solexa1.3-quals --best -S -y
    So here is the thing: the seed length is 30nt, and is a perfect match(on reverse strand), so it ought to be reported. But why not?

    Thanks in advance!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...